SALVADOR ANTONIO ARIAS SANTIAGO-rekin lankidetzan egindako argitalpenak (26)

2017

  1. The value of hypercalciuria in patients with osteopenia versus osteoporosis

    Urolithiasis, Vol. 45, Núm. 3, pp. 279-283

2016

  1. Analysis of vitamin D deficiency in calcium stone-forming patients

    International Urology and Nephrology, Vol. 48, Núm. 8, pp. 1243-1246

  2. Bone remodeling markers as lithogenic risk factors in patients with osteopenia–osteoporosis

    International Urology and Nephrology, Vol. 48, Núm. 11, pp. 1777-1781

  3. Optimización del cultivo de queratinocitos humanos para el desarrollo de un modelo de piel artificial humana: alternativas celulares como capa alimentadora

    Actualidad médica, Tomo 101, Núm. 798, pp. 85-94

2015

  1. Retrospective Review of Serum and Urinary Lithogenic Risk Factors in Patients with Osteoporosis and Osteopenia

    Urology, Vol. 85, Núm. 4, pp. 782-785

2013

  1. Association of severe calcium lithogenic activity and bone remodeling markers

    Urology, Vol. 82, Núm. 1, pp. 16-21

  2. Bone and metabolic markers in women with recurrent calcium stones

    Korean Journal of Urology, Vol. 54, Núm. 3, pp. 177-182

  3. Calcium renal lithiasis and bone mineral density. Importance of bone metabolism in urinary lithiasis

    Actas Urologicas Espanolas

  4. Effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria, and recurring renal calcium lithiasis

    Urology, Vol. 81, Núm. 4, pp. 731-737

  5. Importance of citrate and the calcium: Citrate ratio in patients with calcium renal lithiasis and severe lithogenesis

    BJU International, Vol. 111, Núm. 4, pp. 622-627

  6. Recurrent renal colic: A case study

    Australian Family Physician

2012

  1. Alendronate in patients with calcium nephrolithiasis and loss of bone mass

    Central European Journal of Medicine, Vol. 7, Núm. 4, pp. 429-434

  2. Androgenetic alopecia as an early marker of benign prostatic hyperplasia

    Journal of the American Academy of Dermatology, Vol. 66, Núm. 3, pp. 401-408

  3. Fournier gangrene: Description of 37 cases and analysis of associated health care costs

    Actas Dermo-Sifiliograficas, Vol. 103, Núm. 1, pp. 29-35

  4. Hypercalciuria, hyperoxaluria, and hypocitraturia screening from random urine samples in patients with calcium lithiasis

    Urological Research, Vol. 40, Núm. 5, pp. 511-515

  5. Metabolic syndrome, hormone levels, and inflammation in patients with erectile dysfunction

    The Scientific World Journal, Vol. 2012

  6. Metabolic-mineral study in patients with renal calcium lithiasis, severe lithogenic activity and loss of bone mineral density

    Singapore Medical Journal, Vol. 53, Núm. 12, pp. 808-813

  7. Osteopenia/osteoporosis in patients with calcium nephrolithiasis

    Urological Research, Vol. 40, Núm. 6, pp. 709-716

  8. Síndrome metabólico y perfil hormonal en pacientes con disfunción eréctil

    Actas Urologicas Espanolas, Vol. 36, Núm. 4, pp. 222-227

  9. What is the value of bone remodeling markers in patients with calcium stones?

    Urological Research